Wird geladen...

Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond

Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s. Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, which acts as a central integrator...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cold Spring Harb Perspect Med
1. Verfasser: Lamming, Dudley W.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Cold Spring Harbor Laboratory Press 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4852795/
https://ncbi.nlm.nih.gov/pubmed/27048303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a025924
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!